Elevated plasma levels of homocysteine have been shown to interfere with normal cell function in a variety of tissues and organs, such as the vascular wall and the liver. However, the molecular mechanisms behind homocysteine effects are not completely understood. In order to better characterize the cellular effects of homocysteine, we have searched for changes in gene expression induced by this amino acid. Our results show that homocysteine is able to induce the expression and synthesis of the tissue inhibitor of metalloproteinases-1 (TIMP-1) in a variety of cell types ranging from vascular smooth muscle cells to hepatocytes, HepG2 cells and hepatic stellate cells. In this latter cell type, homocysteine also stimulated K1(I) procollagen mRNA expression. TIMP-1 induction by homocysteine appears to be mediated by its thiol group. Additionally, we demonstrate that homocysteine is able to promote activating protein-1 (AP-1) binding activity, which has been shown to be critical for TIMP-1 induction. Our findings suggest that homocysteine may alter extracellular matrix homeostasis on diverse tissular backgrounds besides the vascular wall. The liver could be considered as another target for such action of homocysteine. Consequently, the elevated plasma levels of this amino acid found in different pathological or nutritional circumstances may cooperate with other agents, such as ethanol, in the onset of liver fibrosis. ß
Introduction
Elevated blood levels of homocysteine, an intermediate metabolite of methionine, have been identi¢ed as an independent risk factor for peripheral vascular disease and arteriosclerosis (reviewed in [1] ). Hyperhomocysteinemia is caused by genetic factors, such as cystathionine L-synthase de¢ciency [2] , and acquired conditions including de¢cient intake of vitamin B 6 , B 12 and folate [3] , required for homocysteine metabolism. Additionally, impaired liver func-tion has been associated with elevated plasma levels of this amino acid [4^7] . This last situation probably stems from the central role of the liver in the metabolism of methionine and subsequently in the catabolism of homocysteine [8, 9] .
Regarding the pathological mechanisms behind homocysteine-induced cellular toxicity it has been observed that di¡erent cell types can be targeted by this amino acid. Endothelial injury resulting in a deranged NO production, and consequently an impaired platelet modulating activity has been clearly established [10, 11] . Along with this e¡ect on the vessel wall, homocysteine is able to promote DNA synthesis and to enhance collagen production in vascular smooth muscle cells (VSMCs) [12^15] . In addition, it has been recently demonstrated that hepatic cells produce and secrete more cholesterol in response to homocysteine [16] . Taken together, these observations suggest that homocysteine exerts its e¡ects on a variety of cellular backgrounds, and thus the deleterious consequences of hyperhomocysteinemia may spread over di¡erent tissues and organs.
In order to gain more insight into the molecular mechanisms responsible for the interference of homocysteine in normal cell function, we have searched for genes whose expression could be altered in the presence of physiopathological concentrations of this amino acid. In this report, we describe the induction by homocysteine of the tissue inhibitor of metalloproteinases-1 (TIMP-1) [17] . This e¡ect of homocysteine, that we initially observed in VSMCs in culture, could be demonstrated in other cell types, such as hepatic stellate cells (HSC) and hepatocytes. TIMP-1 is a low molecular weight glycoprotein that plays a key role in the regulation of extracellular matrix (ECM) accumulation through its ability to inhibit matrix metalloproteinases (MMPs). When TIMP-1 is produced in excess the net MMP activity is reduced. This situation has been proposed to be of importance in the development of liver ¢brosis [18] . High TIMP-1 levels have been observed in diseased human liver [19, 20] and experimental models of liver injury [20^22] , situations in which elevated plasma concentrations of homocysteine occur [4^7]. Our results showing a direct e¡ect of homocysteine on the induction of TIMP-1 and K1(I) procollagen expression suggest that elevated levels of this amino acid may participate in the pathogenesis of liver ¢brosis.
Materials and methods

Materials
D,L-Homocysteine was from Sigma (St. Louis, MO). Cell culture media, fetal bovine serum and antibiotics were from Gibco-BRL (Paisley, UK). Anti TIMP-1 monoclonal antibody was from Calbiochem (San Diego, CA). Radioactive isotopes were purchased from Amersham (Little Chalfont, UK). All other reagents were of the best quality commercially available.
Methods
Cell culture
The hepatic stellate cells (HSC) clone CFSC-2G derived from CCL 4 -treated rats [23] , kindly provided by Dr. Marcos Rojkind, was maintained in minimal essential medium (MEM) supplemented with 10% fetal calf serum and non-essential amino acids. This cell line has a similar phenotype to that of freshly isolated HSC. Human hepatoma cell line HepG2 was kept in Dulbecco's modi¢ed Eagle's medium (DMEM) plus 10% fetal calf serum. In all the cases, media was supplemented with 2 mmol/l glutamine, 100 U/ml penicillin and 50 mg/ml streptomycin sulfate. All experiments with these cells were performed in serum-free medium supplemented with 0.2% bovine serum albumin fraction V (Sigma).
Human VSMCs were isolated from mammary artery using the explant method, accordingly with previously described procedures [24] . Porcine VSMCs were isolated from aorta of Yucatan mini-pigs, in sterile conditions, immediately after animal sacri¢ce. Immunohistochemical characterization of VSMC isolates was performed on primary cultures, using speci¢c antibodies against smooth muscle speci¢c K-actin (Dako, High Wycombe, UK). VSMCs were grown in DMEM supplemented with antibiotics as described above plus fungizone (Gibco-BRL) and 10% fetal calf serum. Experiments described herein used di¡erent isolates of VSMC between passages 3 and 6. Subcon£uent cultures of VSMCs were washed twice with DMEM and rendered quiescent by serum deprivation and maintenance in serum-free medium (DMEM/F12, Gibco-BRL) containing insulin, transferrin and sodium selenite (ITS-x, Gibco-BRL) for 48 h before the beginning of the experimental procedures. Incubations with D,L-homocysteine were carried out in serum-free DMEM medium.
Rat hepatocytes were isolated and cultured as previously described [25] . Cultures were kept in 0.5% fetal calf serum for 16 h before treatments, which were carried out in the absence of serum.
All cells were maintained at 37³C in a humidi¢ed incubator containing 21% oxygen and 5% carbon dioxide in air.
The investigation was performed in accordance with the European Community guidelines for animal ethical care and use of laboratory animals (Directive 86/609), and ful¢lled the ethical requirements of this University.
Di¡erential display analysis
Total cellular RNA was isolated by extraction with guanidinium thiocyanate followed by centrifugation in a cesium chloride solution as previously described [26] . A 25-Wg amount of total RNA was incubated for 30 min at 37³C with 10 U of RNasefree DNase I (Boehringer Mannheim, Mannheim, Germany) in 10 mmol/l Tris HCl pH 7.5, 10 mmol/ l MgCl 2 , then samples were phenol:chloroform extracted and ethanol precipitated in the presence of 0.3 mol/l sodium acetate. RNA was redissolved in sterile nuclease-free water.
Di¡erential display was performed using oligo(dT) anchored primers [26, 27] (2 min), and an additional ¢nal extension step at 72³C for 7 min. Reactions were performed with each cDNA solution in duplicate. Control reactions were set using sterile nuclease-free water or each DNase-treated RNA instead of the cDNA solution.
Following di¡erential display PCR, radiolabeled cDNA fragments were electrophoretically separated on 4.5% polyacrylamide gels under denaturing conditions in a Genomyx LR DNA sequencer (Genomyx, Beckman). Gels were dried and exposed to produce an autoradiograph. Bands of interest were excised from the gel, and the gels slides were placed directly into PCR tubes and covered with 40 Wl of PCR mix (24.4 Wl sterile nuclease-free water, 3.2 Wl dNTP mix, 4 Wl T7 promoter 22-mer primer (2 Wmol/ l), 4 Wl M13 reverse 24-mer primer (2 Wmol/l), 2.4 Wl MgCl 2 (25 mmol/l), 4 Wl AmpliTaq PCR Bu¡er (10U), and 0.4 Wl AmpliTaq enzyme (5 U/Wl)). PCR was performed as follows: 95³C (2 min), 4 cycles at 92³C (15 s), 50³C (30 s), and 72³C (2 min), 30 cycles at 92³C (15 s), 60³C (30 s), and 72³C (2 min), and an additional extension step at 72³C for 7 min. Ampli¢ed DNA fragments were cloned into the plasmid vector pCR2:1-TOPO using TOPO-TA Cloning Kit (Invitrogen, Leek, The Netherlands) and sequenced in both directions using M13 reverse (324) primer and M1 forward (320) primer. Nucleotide sequence homology search analysis of the EMBL [28] and GeneBank [29] databases were performed using the program FASTA [30] .
RNA isolation and Northern blot analysis
Total RNA from the di¡erent cell lines used was isolated by the guanidinium thiocyanate method [31] . Aliquots (20 Wg) of total RNA were size-fractionated by electrophoresis in a 1% agarose gel under denaturing conditions. RNAs were then blotted and ¢xed to Nytran membranes (Schleicher and Schuell, Keene, NH). Prehybridization and hybridization were performed as described previously [32] . Probes used were the isolated clone from di¡erential display (clone 3.3) and a 1.6-kb cDNA fragment of procollagen K1 [33] . Equal loading of the gels was assessed by hybridization with a probe speci¢c for L-actin. The probes were labeled with [K-32 P]dCTP (3000 Ci/mmol) by random priming using the Megaprime DNA labeling system (Amersham). Speci¢c activity was usually approximately 5U10 8 cpm/Wg of DNA. Quantitation was performed by scanning densitometry of the X-ray ¢lms.
Immunoblot analysis
Conditioned media from equal number of HepG2 cells were collected after treatments and concentrated 10-fold using Centricon 3 concentrators (Amicon, Beverly, MA). Samples were subjected to 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were electrophoretically transferred to nitrocellulose membranes (Schleicher and Schuell). Immunodetection of TIMP-1 was performed using a monoclonal anti TIMP-1 antiserum (Calbiochem) and a horseradish peroxidase-conjugated secondary antibody. Blots were developed by enhanced chemiluminescence according to the manufacturer's instructions (Dupont, Boston, MA).
Nuclear protein extraction and electrophoretic
mobility shift assays (EMSA) Rat hepatocytes were incubated in low serum (0.5%) for 16 h before treatment. Nuclear proteins from control and treated cells were isolated following the method described by Schreiber et al. [34] . An oligonucleotide containing the AP-1 consensus sequence (5P-TTCCGGGTGACTCATCAAGCG-3P) (Promega), was labeled with [Q-32 P]ATP using T4 polynucleotide kinase. The reaction mixture (25 Wl ¢nal volume) containing 40% glycerol, 1 Wg of dIdC, 10 mmol/l EDTA, 20 mmol/l DTT, 100 mmol/l Tris HCl bu¡er pH 7.5, 10 000 cpm of labeled oligonucleotide and 10 Wg of nuclear extract was incubated for 30 min at room temperature. DNA^protein complexes were separated from unbound probe by electrophoresis on a 5% polyacrylamide gel. Complexes formed were identi¢ed by autoradiography of the dried gels. For competition studies, the reaction was carried out as described above, but in the presence of the indicated concentration of unlabeled probe.
Statistics
The data shown are the means þ S.E.M. of at least three independent experiments. Statistical signi¢-cance was estimated with Student's t-test. A P-value of less than 0.05 was considered signi¢cant.
Results
Di¡erential display analysis was carried out on human VSMCs isolated from mammary artery. Cells were made quiescent by serum deprivation and then treated with 100 Wmol/l of homocysteine, a concentration compatible with intermediate hyperhomocysteinemia [1] , for 24 h in DMEM medium. After this treatment total RNA was isolated and the di¡er-ential display analysis was performed as described in Section 2. Several bands were di¡erentially expressed in cells treated with homocysteine as compared with control cultures. One of the bands selected for analysis, whose expression was induced in homocysteine-treated cells (Fig. 1A) , was excised from the gel, ampli¢ed and sequenced. This clone of about 0.6 kb (termed clone 3.3) had a sequence 100% identical to part of the human TIMP-1 cDNA (nucleotides 165^615) [35] and could hybridize a 0.9-kb mRNA in total cellular RNA from human VSMCs (Fig. 1B) . The band detected in Northern blot by clone 3.3 corresponded in size to that reported for TIMP-1 transcript in other human cell lines [36, 37] , and was induced 2-fold upon treatment with homocysteine, thus con¢rming the induction detected in the di¡erential display gel. The e¡ect of homocysteine on TIMP-1 expression was also tested on VSMCs obtained from pig aorta. As shown in Fig. 1C , incubation of these cells with 100 Wmol/l of homocysteine for 24 h resulted in a 2.5-fold induction in TIMP-1 mRNA, demonstrating that this e¡ect was not species speci¢c. Given the central role played by HSC in liver matrix biology [38, 39] , we next examined TIMP-1 levels in response to homocysteine in a rat HSC line. As shown in Fig.  1D , treatment of HSC with 150 Wmol/l of homocysteine for 4 h resulted in a 1.5-fold increase in TIMP-1 mRNA levels. HSC response to homocysteine was maximal after 4 h of treatment and dosedependency was studied at this time point as shown in Fig. 2A . Homocysteine has been reported to induce the expression of K1(I) procollagen mRNA and to promote collagen synthesis in VSMCs in culture [13, 14] . We have examined whether homocysteine could elicit a similar response on HSCs. Treatment of HSCs with increasing concentrations of homocysteine resulted in a dose-dependent increase in K1(I) procollagen mRNA, reproducing in this cell type the response described by others in VSMCs (Fig. 2B) .
Another important source of TIMP-1 within the liver tissue is the parenchymal cell. TIMP-1 is induced in hepatocytes in diseased human liver [40] and in di¡erent models of liver injury as well as in rat hepatocytes in primary culture by cytokines [41] . These observations prompted us to examine whether homocysteine could promote a similar response in isolated rat hepatocytes. Treatment of cultured rat hepatocytes with di¡erent concentrations of homocysteine resulted in the induction of TIMP-1 mRNA. Fig. 2C shows TIMP-1 mRNA levels in response to 500 Wmol/l homocysteine (the concentration which elicited a maximal e¡ect) after 8 and 24 h of incubation (Fig. 2C) . We next tested whether homocysteine induction of TIMP-1 mRNA resulted in enhanced production of TIMP-1 protein. For this purpose we used the di¡erentiated human hepatoma cell line HepG2, a hepatic cell line in which TIMP-1 expression and secretion has been thoroughly characterized in response to cytokines and phorbol esters [42] . HepG2 cells were incubated in the presence of increasing concentrations of homocysteine for 24 h in serum free DMEM, then conditioned media were collected and concentrated as described in Section 2. Samples were analyzed for the presence of TIMP-1 protein by Western blotting. As shown in Fig. 2D , homocysteine induced a dose-dependent accumulation of TIMP-1 protein in the medium of treated cells, as evidenced by the detection of a single 29-kDa band, the reported size of TIMP-1 protein [17] . This e¡ect was already observed at 50 Wmol/l homocysteine and was maximal at 250 Wmol/l.
It has been suggested that some cellular e¡ects of homocysteine could be mediated by its thiol group [13, 14] . We have tested the e¡ect of other thiol-containing reagents, such as cysteine and L-mercaptoethanol, on TIMP-1 expression. Treatment of HSCs for 4 h with these compounds (at concentrations of 500 Wmol/l) resulted in the upregulation of TIMP-1 mRNA (Fig. 3) . Interestingly, methionine treatment for the same period of time also promoted TIMP-1 Fig. 3 . TIMP-1 induction in HSCs by thiol-bearing agents and methionine. HSCs were treated with 500 Wmol/l of homocysteine, methionine, cysteine or L-mercaptoethanol for 4 h, TIMP-1 mRNA levels were assayed by Northern blotting. Blots were probed with L-acting for loading control, a representative blot is shown. Asterisks denote statistical signi¢cance (P 6 0.05).
expression. It must be noted, however, that regular culture media already contain methionine and cysteine at concentrations of 300 Wmol/l.
In the regulation of TIMP-1 gene expression, AP-1 elements present in its promoter have been shown to play a critical role in mediating the response to serum factors and other agonists, such as phorbol esters [43, 44] . These observations, together with the ability of homocysteine to induce protein kinase C (PKC) and MAP kinase activation and c-fos expression [45, 46] , led us to examine if homocysteine could induce AP-1 binding activity. For this purpose rat hepatocytes were treated with di¡erent concentrations of homocysteine, then nuclear extracts were prepared and subjected to EMSA analysis using an oligonucleotide containing the consensus AP-1 sequence. Homocysteine treatment for 2 h of cultured rat hepatocytes resulted in the dose dependent induction of a speci¢c bandshift (Fig. 4A) , which could be competed by an excess of the same unlabeled oligonucleotide harboring the consensus AP-1 binding site and was not competed by a random oligonucleotide of the same length (Fig. 4B ).
Discussion
Hyperhomocysteinemia is a condition in which plasma levels of homocysteine are transiently or persistently elevated. This situation may develop as a consequence of a variety of genetic backgrounds, such as de¢ciencies in cystathionine L-synthase or methylenetetrahydrofolate reductase, and pathological or nutritional conditions leading to vitamin B 6 , B 12 or folate de¢ciencies [1] . In addition, impaired liver function may lead as well to the elevation of plasma homocysteine. In this regard, hyperhomocysteinemia has been reported in chronic alcohol consumption with a homocysteine plasma concentration up to 40 Wmol/l [6, 7] . This homocysteine elevation also appears in experimental models of ethanol and CCl 4 -induced liver damage (2.5-and 20-fold increase above basal levels of homocysteine respectively) [4, 5] , probably re£ecting the central role played by this organ in homocysteine catabolism [9] . While the mechanisms that lead to an increased plasma homocysteine have been quite well established, the molecular basis of homocysteine-mediated alteration of cellular function are not completely understood. In an e¡ort to gain more insight into this issue we have searched for genes whose expression could be modulated by this amino acid. For this purpose we have carried out di¡erential display analysis in VSMCs, a well characterized cellular target of homocysteine. In this cell type, homocysteine promotes DNA synthesis and cell growth, and enhances collagen production [12^15,45] . One of the homocysteine-respondent genes identi¢ed in our study coded for the TIMP-1 protein. TIMP-1 is a member of the tissue inhibitor of the metalloproteinases family, a secretory glycoprotein able to control the activity of MMPs through the direct interaction with these enzymes [17] . We have observed that homocysteine upregulates TIMP-1 mRNA levels in primary cultures of human and pig VSMCs. This novel action of homocysteine provides further information on the mechanisms by which this amino acid promotes net collagen deposition in the atherosclerotic lesion [11, 47] . Given the central role that TIMP-1 plays in the regulation of ECM homeostasis we wanted to know whether this response to homocysteine would also take place in another scenario, such as liver tissue, in which matrix production has to be tightly controlled. Our results indicate that homocysteine is able to promote TIMP-1 mRNA expression in a HSCs clone and cultured hepatocytes, as well as the secretion of TIMP-1 protein by the hepatic cell line HepG2. Nevertheless, it would be interesting to determine whether TIMP-1 induction by homocysteine occurs in freshly isolated HSCs as it does in our HSC cell line, which in some aspects behave like activated HSCs. We have also observed that homocysteine promotes the expression of K1(I) procollagen mRNA in our HSCs clone. This later e¡ect has been already reported for VSMCs in culture treated with homocysteine [13, 14] and together with our present ¢ndings support a role for homocysteine in the regulation of ECM homeostasis in diverse tissular backgrounds.
Enhanced TIMP-1 production by HSCs and hepatocytes has been documented in experimental models of cholestatic and CCl 4 -induced liver damage [22, 48] and in patients with chronic liver disease [19, 20, 40] . Additionally, elevated plasma levels of TIMP-1 have been proposed as an early marker of ¢brosis and precirrhotic states in humans [49] . As mentioned above, most of these situations of liver damage are accompanied by a rise in plasma homocysteine. However, to our knowledge, a direct role for this amino acid in the impairment of liver ECM regulation had not been so far established. Interestingly, the hepatic lesion observed in patients with homocystinuria, characterized by fatty in¢ltra-tion, can be accompanied by perisinusoidal or central venous ¢brosis and ¢brosis of hepatic arterioles [50] .
Previous studies have reported on the role of homocysteine thiol group in mediating many of the cellular e¡ects of this amino acid [13^15] . We have tested whether other thiol-bearing compounds could have an e¡ect on TIMP-1 mRNA expression. Treatment of HSCs with cysteine or L-mercaptoethanol resulted as well in the induction of TIMP-1 mRNA. Interestingly, methionine treatment gave a similar response. This might be explained by its rapid metabolic conversion into homocysteine [8, 51, 52] . These observations are in agreement with the previously reported induction of collagen synthesis by cysteine in VSMCs [14] and TIMP-1 expression in ¢bro-blasts in response to reduced glutathione [53] , and support the hypothesis of the implication of homocysteine sulfhydryl group in the mediation of some of the biological e¡ects of this amino acid. Although the observed e¡ect of cysteine on TIMP-1 induction may be of interest from a mechanistic point of view regarding a thiol-mediated e¡ect, this e¡ect is unlikely to have physiological or pathological signi¢-cance. Such high cysteine concentrations are not observed even in patients with defects in cysteine metabolism [54] , while the concentrations of homocysteine used in our experiments can be found in patients with intermediate and severe hyperhomocysteinemia [1] .
The control of TIMP-1 expression, which mainly occurs at the transcriptional level, has been thoroughly characterized. The study of its promoter region has allowed the identi¢cation of the transcription factors critical for its regulation [43, 44] . In this regard, AP-1 has been shown as one of the key factors that interact with TIMP-1 promoter and activate its transcription. This information, together with the recently described ability of homocysteine to promote PKC and MAP kinase activation and c-fos induction [45, 46] , prompted us to evaluate whether homocysteine treatment could result in an increased AP-1 binding activity. Our results indicate that this is the case, as evidenced by the appearance of speci¢c bandshifts for AP-1 in EMSA assays using nuclear extracts from rat hepatocytes treated with homocysteine. Our data agree with the previously reported induction of AP-1 by other thiol reagents, such as dithiocarbamates and N-acetylcysteine, which are able to promote c-fos and c-jun induction [55] .
Taken together, our results indicate that homocysteine may contribute to the deposition of ECM by di¡erent, but converging mechanisms. In response to elevated levels of homocysteine cells such as VSMC and HSC respond producing more collagen. The concomitant induction of TIMP-1 in the same cell types and in neighboring hepatocytes would prevent its degradation favoring the net accumulation of ECM. In the vascular wall, this would result in the promotion of atherogenesis while in the liver tissue, the same situation may favor the progression of liver ¢brosis. Furthermore, the elevated plasma levels of homocysteine, that accompany chronic alcohol consumption, genetic defects in its metabolism, and vitamin de¢ciencies, could be considered as a novel risk factor for liver disease. Homocysteine may thus cooperate in the onset of liver ¢brosis under diverse pathological circumstances potentiating the e¡ects of other agents, such as ethanol and cytokines [56] .
